HOME >> BIOLOGY >> NEWS
In limiting life span, study finds booming bacteria innocent

ndetectable to a million or more per fly.

Using a scanning electron microscope to examine the insects outer surfaces, the researchers showed that some of the bacteria were even banding together, forming continuous biofilms. Yet treatments that reduced the number of bacteria had no effect on life span, they found. That discovery led the researchers to conclude that, at least under optimal laboratory conditions, Drosophila can tolerate a significant number of bacteria and mount a strong innate immune response against them without cutting their 65-day lives any shorter.

There has been some thinking in general that life span is regulated according to trade-offsthat the body has only so much energy to devote to different processes, Tower said. If you devote a lot [of energy] to controlling bacteria, preventing them from growing to a toxic level, then that energy isnt available to maintain tissues and organs. However, we found no effect on the animals longevity even when their bacteria are taken from one extreme to the other.

Nevertheless, he added, the bacterial infestations seen in the aged flies have to be a quality of life issue.


'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
7-Aug-2007


Page: 1 2

Related biology news :

1. UCI researchers define estrogens role in limiting heart disease in women
2. New study warns limited carbon market puts 20 percent of tropical forest at risk
3. Clones on task serve greater good, evolutionary study shows
4. Pollution causes 40 percent of deaths worldwide, study finds
5. A study by the MUHC and McGill University opens a new door to understanding cancer
6. New study suggests Concord grape juice may provide protection against breast cancer
7. Preclinical study links gene to brain aneurysm formation
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ... 21 st .  The commercials will air on Bloomberg TV, ... the Street show. --> NXTD ) ("NXT-ID" or ... market, announces the airing of a new series of commercials ...
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation (NYSE: ... Border Protection (CBP) is testing its biometric identity solution ... Diego to help identify certain non-U.S. citizens leaving ... The test, designed to help determine the efficiency and accuracy ... in February and will run until May 2016. --> ...
(Date:3/3/2016)... 3, 2016  FlexTech, a SEMI Strategic Association Partner, ... Research & Development, Leadership in Education, and, in a ... 9 th year of the FLEXI Awards and ... individuals from past years . Judging was done ... set of criteria, by a panel of non-affiliated, independent, ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... RESEARCH TRIANGLE PARK, N.C. , April ... UTHR ) announced today that Martine Rothblatt , ... will provide an overview and update on the company,s ... Health Care Conference. The presentation will take ... Eastern Time, and can be accessed via a live ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells ... Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs in Miami. , ... he studied hematopoietic stem cell transplantation for hematologic disorders and the suppression of graft ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... ... today announced that Ardy Arianpour has joined the company as Chief Business Officer. ... experience bringing innovative genomic technologies to market, was most recently Chief Commercial Officer ...
(Date:4/26/2016)... ... 26, 2016 , ... BioFactura, Inc ., a biopharmaceutical research and manufacturing ... Healthy investor interest drove significant oversubscription of the original $1.5M target. The funds ... the advanced preclinical stages. , Chief Executive Officer and President, Darryl Sampey ...
Breaking Biology Technology:
Cached News: